Aviado · Research
Longevity Daily
Thursday, October 29, 2026
Listen
Today's Brief
Today's lead story is a genuine supplement wake-up call: fish oil successfully raises omega-3 levels in the brain—but that increase yields zero measurable cognitive benefit, challenging one of the most common reasons people take it. On the research front, a novel RNA-splicing factor called SRSF1 extended lifespan in mice without the risks of full cellular reprogramming, while a 13,379-person study reveals that moderate exercise—not high-intensity—produces the best biological aging outcomes. Aviado Research also breaks down one of the more credible antioxidant mechanisms in supplements today: how astaxanthin's unique membrane-spanning structure makes it a cut above standard antioxidants.
10 stories2 peer-reviewed1 Aviado original
Cognitive Health & Neuroprotection
Fish Oil Raises Brain Omega-3 Levels — But Doesn't Improve Cognition, Study Finds
Fish oil supplements are among the most popular in the world, and a new controlled study just delivered an uncomfortable finding: omega-3 supplementation did successfully raise brain omega-3 levels compared to placebo—but that increase produced no measurable cognitive improvement whatsoever. The mechanism everyone assumed mattered (higher brain omega-3s) was confirmed; the outcome everyone was hoping for didn't follow. This is one of the harder supplement findings to explain away, precisely because the expected biological step happened—the cognitive benefit just wasn't there. If you're taking fish oil specifically for brain health, this study deserves serious attention.
Read more →Every Year Your Brain Ages Ahead of Schedule Costs About a Year of Memory
Using structural MRI scans from 4,606 older Icelanders, researchers found that people whose brains look older than their chronological age score measurably lower on memory, processing speed, and executive function—independent of actual age, sex, or education. Every structural year of 'brain age gap' corresponds to roughly a year of lost cognitive performance. The practical implication: anything that preserves brain structure—vigorous exercise, sleep quality, cardiovascular health—also preserves the cognitive function that follows from it.
Read more →Supplements & Compounds
Protein Supplements Add Real Strength Gains on Top of Resistance Training, Meta-Analysis Confirms
A new meta-analysis in Frontiers in Nutrition confirms that combining protein supplementation with resistance training produces meaningful strength gains beyond training alone—specifically +2.6 kg on bench press and +7.4 kg on squat. High heterogeneity across studies (I² >92%) means individual results will vary, but the direction of effect is consistent across the pooled evidence. For anyone over 50 managing muscle loss, this reinforces that protein intake around training sessions is not an optional extra.
Read more →How Astaxanthin Protects Cell Membranes From Oxidative Stress
Astaxanthin's key advantage over most antioxidants is structural: it physically spans the full width of the cell membrane, letting it intercept lipid peroxyl radicals at the point of damage rather than mopping up from inside or outside the cell. Multiple RCTs and meta-analyses confirm this translates to reliably lower malondialdehyde (a validated marker of oxidative damage) in humans, with especially consistent effects in people with metabolic risk factors such as type 2 diabetes. Effective doses run 4–12 mg/day from natural astaxanthin in lipid-based form to maximize absorption; long-term disease outcome data remain limited, but the mechanism is one of the more credible in the antioxidant supplement space.
Read the full Aviado analysis →Research & Papers
A Safer Path to Cellular Rejuvenation: Splicing Factor SRSF1 Extends Lifespan in Mice
Researchers have identified SRSF1, an RNA-splicing factor, as capable of producing epigenetic rejuvenation in human cells in vitro and extending lifespan and healthspan in mice—without the cancer and cellular-instability risks associated with full Yamanaka reprogramming. Because each splicing factor regulates thousands of genes simultaneously, SRSF1 could produce broad rejuvenation effects from a single intervention point. This is early-stage mouse and cell data, but it marks a meaningful step toward clinically tractable partial reprogramming strategies.
Read more →21-Year Study: Lifestyle Changes Decisively Outperform Metformin for Long-Term Health
A 21-year study found that lifestyle interventions—primarily diet and exercise—decisively outperformed metformin for long-term health outcomes, and that advantage held even after excluding diabetes cases from the analysis. Metformin made little measurable difference over the study period, adding to a growing body of evidence that the drug's longevity potential may be overstated relative to what sustained lifestyle change can accomplish. For those taking metformin off-label for aging, this is worth a candid conversation with your physician.
Read more →An Oral 'Age-Reversal Pill' Shows Early Promise in Mice — Here's What We Know
A chemical cocktail called SL-100 is generating early interest as an oral approach to cellular age reversal, with preliminary mouse results showing protection against frailty markers. The key differentiator is delivery: unlike gene-based reprogramming approaches, SL-100 is designed to be taken as a pill, which—if it works in humans—would dramatically lower the barrier to access. This is early animal data only, and human trials remain a long way off; treat this as a watch-list story, not a recommendation.
Read more →Lifestyle & Nutrition
Peter Attia's Longevity Playbook for Building Strength That Lasts
Peter Attia and Michael Rae lay out a practical, longevity-oriented framework for building and maintaining strength—focused on how to train in ways that remain sustainable over decades, not just years. The piece emphasizes that the real goal isn't peak performance in your 40s but maintaining the physical capacity to do what you love in your 70s and 80s. Required reading for anyone who hasn't yet formalized their resistance training strategy.
Read more →Moderate Exercise Beats High-Intensity for Biological Aging Markers in 13,000-Person Study
A cross-sectional study of 13,379 Americans found that moderate physical activity (600–3,000 MET-min/week) was consistently associated with better biological aging markers across four different measurement methods—but high-intensity exercise (>3,000 MET-min/week) showed no additional benefit and in some measures a reversed effect. Dose-response curves peaked at moderate activity levels for allostatic load, phenotypic age acceleration, and Klemera-Doubal biological age—three independent clocks telling the same story. Important caveat: this is cross-sectional, so causation can't be proven, but the consistency across four distinct aging metrics strengthens the signal considerably.
Read more →Industry & Policy
Fierce Biotech's 2026 Graveyard: Who Didn't Make It — and What It Means for Longevity
Fierce Biotech's annual Halloween 'biotech graveyard' catalogs the companies that didn't survive 2026—a tradition that this year arrives alongside genuine signs of sector recovery, with the XBI showing renewed strength after years of contraction. The list serves as a useful reality check: even in an improving funding environment, late-stage failures in capital-intensive disease areas keep accumulating. For longevity-sector watchers, tracking who folded and why is as informative as watching the survivors.
Read more →